Johnson & Johnson vaccine halted after several patients develop blood clots.
Image Credit: newson6.com
In a joint statement the Centers for Disease Control (CDC) and Prevention and the Food and Drug Administration (FDA) recommended to halt the COVID-19 single-dose Johnson & Johnson vaccine, after six recipients, all women, developed blood clots and also low platelets, weeks after vaccination.
So far, the US administered more than 6.8 million doses of the vaccine. On Wednesday a discussion regarding the vaccine’s link to blood clots will be held. The FDA also launched an investigation to analyze the link between the vaccine and blood clots.
We are recommending a pause in the use of this vaccine out of an abundance of caution.Dr. Peter Marks, director of the Food and Drug Administration’s Center for Biologics Evaluation and Research.
Undoubtedly, this would hamper Biden’s plan to vaccinate the entire US population by the end of May. It is not yet known to what degree Biden’s vaccination plan will be set back.
More details to follow.